Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024
Compare Balance Sheet Results of Asston Pharmaceu
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.27
10.25
-3.98
-38.83%
Share Warrants & Outstandings
Total Reserve
4.76
63.40
-58.64
-92.49%
Shareholder's Funds
11.04
73.66
-62.62
-85.01%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.26
19.40
-17.14
-88.35%
Secured Loans
0.80
10.68
-9.88
-92.51%
Unsecured Loans
1.45
8.73
-7.28
-83.39%
Deferred Tax Assets / Liabilities
-0.02
11.35
-11.37
-100.18%
Other Long Term Liabilities
0.16
0.00
0.16
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.52
-1.52
-100.00%
Total Non-Current Liabilities
2.39
32.27
-29.88
-92.59%
Current Liabilities
Trade Payables
5.97
8.58
-2.61
-30.42%
Other Current Liabilities
3.70
3.35
0.35
10.45%
Short Term Borrowings
5.00
49.24
-44.24
-89.85%
Short Term Provisions
0.00
1.11
-1.11
-100.00%
Total Current Liabilities
14.67
62.28
-47.61
-76.45%
Total Liabilities
28.10
168.21
-140.11
-83.29%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.10
109.10
-108.00
-98.99%
Less: Accumulated Depreciation
0.14
47.13
-46.99
-99.70%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.96
61.97
-61.01
-98.45%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.09
-0.09
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
1.70
-1.70
-100.00%
Other Non Current Assets
0.00
0.94
-0.94
-100.00%
Total Non-Current Assets
0.96
96.82
-95.86
-99.01%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.72
16.74
-16.02
-95.70%
Sundry Debtors
24.55
48.50
-23.95
-49.38%
Cash and Bank
0.20
3.08
-2.88
-93.51%
Other Current Assets
0.14
1.19
-1.05
-88.24%
Short Term Loans and Advances
1.55
1.88
-0.33
-17.55%
Total Current Assets
27.15
71.39
-44.24
-61.97%
Net Current Assets (Including Current Investments)
12.47
9.11
3.36
36.88%
Total Current Assets Excluding Current Investments
27.15
71.39
-44.24
-61.97%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.10
168.21
-140.11
-83.29%
Contingent Liabilities
0.00
1.95
-1.95
-100.00%
Total Debt
7.26
68.64
-61.38
-89.42%
Book Value per share (adjusted)
17.60
55.51
-37.91
-68.29%
Annual - Borrowings
Borrowings 7.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs 29.90% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs -14.16% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 27.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.74% vs 77.92% in Mar 2024






